Biogen (BIIB)

R&D to Revenue

18.11%

Quarterly · Period ending:

BIIB logo

BIIB R&D to Revenue

Latest reported18.11%
BIIB Quarterly R&D/Revenue (0.00% → 18.11%)
High-resolution chart · PNG

BIIB r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen R&D to Revenue — Quarterly
Period endingR&D to Revenue
30.3617%
30.6986%
30.0139%
40.4263%
31.1048%
29.0554%
26.7393%
28.3109%
26.9413%
29.6995%
29.0569%
33.6532%
32.6863%
32.4017%
26.3446%
36.7793%
34.632%
39.9789%
45.9815%
31.405%
71.1165%
71.2209%
43.789%
66.3717%
65.1376%
63.75%
43.8082%
71.6981%
80.1829%
56.5534%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.